ACTIN-N Drug Patent Profile
✉ Email this page to a colleague
When do Actin-n patents expire, and when can generic versions of Actin-n launch?
Actin-n is a drug marketed by Sherwood Medcl and is included in one NDA.
The generic ingredient in ACTIN-N is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ACTIN-N?
- What are the global sales for ACTIN-N?
- What is Average Wholesale Price for ACTIN-N?
Summary for ACTIN-N
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 108 |
| Patent Applications: | 5,664 |
| DailyMed Link: | ACTIN-N at DailyMed |
US Patents and Regulatory Information for ACTIN-N
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sherwood Medcl | ACTIN-N | nitrofurazone | DRESSING;TOPICAL | 017343-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
